IXC 1.35% 7.5¢ invex therapeutics ltd

Ann: Appendix 3G - Issue of Options, page-2

  1. 335 Posts.
    lightbulb Created with Sketch. 147
    Hmmm, any thoughts?

    Seems like it's one of the directors executing their options. Which is odd, since they have until 2023 to execute. One of two possibilities:
    1. They think here is a good time to get stock so they can sell at this price
    2. They think it's a good time to hold stock so they can sell 60K shares at a higher price post announcement of their Phase 2 result this quarter.

 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.